Problem statement: Answer the multiple-choice question.
Question: Which drug has a 18.320\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCCCN(C(=O)c1cccc(C)c1)c1c(N)n(CCC)c(=O)[nH]c1=O
b: CCn1c(SCC(=O)N2CCN(c3ccccc3)CC2)nnc1-c1cc2cc(Cl)ccc2o1
Answer: a. CCCCN(C(=O)c1cccc(C)c1)c1c(N)n(CCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)c1cccc(C)c1)c1c(N)n(CCC)c(=O)[nH]c1=O
CCCCN(C(=O)c1cccc(C)c1)c1c(N)n(CCC)c(=O)[nH]c1=O
N-(6-amino-2,4-dioxo-1-propylpyrimidin-5-yl)-N-butyl-3-methylbenzamide